CHAMPIONS ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $0 for the 12-month period ending 2015-04-30, per its 10-K filed 2015-07-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2015-07-29
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2014-04-30 was $15.00K.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2014-01-31 was -$7.50K.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2014 was $15.00K, a 55.88% decline from fiscal 2013.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2013 was $34.00K, a 59.52% decline from fiscal 2012.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2012 was $84.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2015-04-30 | $0.00 10-K · filed 2015-07-29 | |||
| 2014-04-30 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | $7.50K derived: sum of 2 quarters · filed 2015-07-29 | $15.00K 10-K · filed 2015-07-29 | |
| 2014-01-31 | -$7.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $0.00 10-Q · filed 2014-03-14 | ||
| 2013-10-31 | $7.50K 10-Q · filed 2013-12-13 | |||
| 2013-04-30 | $34.00K 10-K · filed 2014-07-28 | |||
| 2012-10-31 | $11.00K 10-Q · filed 2013-12-13 | |||
| 2012-04-30 | $84.00K 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |